Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Kewaunee Scientific (KEQU) over the last 15 years, with Q4 2025 value amounting to $2.9 million.

  • Kewaunee Scientific's Other Accumulated Expenses rose 12457.36% to $2.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $2.9 million, marking a year-over-year increase of 12457.36%. This contributed to the annual value of $3.3 million for FY2025, which is 21684.01% up from last year.
  • According to the latest figures from Q4 2025, Kewaunee Scientific's Other Accumulated Expenses is $2.9 million, which was up 12457.36% from $4.0 million recorded in Q3 2025.
  • Kewaunee Scientific's Other Accumulated Expenses' 5-year high stood at $4.0 million during Q3 2025, with a 5-year trough of $850000.0 in Q4 2023.
  • In the last 5 years, Kewaunee Scientific's Other Accumulated Expenses had a median value of $1.5 million in 2021 and averaged $2.0 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 4688.25% in 2023, then skyrocketed by 21684.01% in 2025.
  • Quarter analysis of 5 years shows Kewaunee Scientific's Other Accumulated Expenses stood at $1.3 million in 2021, then grew by 6.45% to $1.4 million in 2022, then crashed by 40.14% to $850000.0 in 2023, then surged by 51.76% to $1.3 million in 2024, then surged by 124.57% to $2.9 million in 2025.
  • Its Other Accumulated Expenses was $2.9 million in Q4 2025, compared to $4.0 million in Q3 2025 and $3.3 million in Q2 2025.